Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of the SOFA2-GIS Score: Adding a Gastrointestinal Subscore to SOFA2 for Mortality Risk Assessment in Critically Ill Patients - A Multicenter Prospective Observational Cohort Study

NCT07586254 is registered in ClinicalTrials.gov with Ozkul Yilmaz Colak as lead sponsor.

NCT NCT07586254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of the SOFA2-GIS Score: Adding a Gastrointestinal Subscore to SOFA2 for Mortality Risk Assessment in Critically Ill Patients - A Multicenter Prospective Observational Cohort Study
Lead sponsor
Ozkul Yilmaz Colak
Phase
Observational
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
March 31, 2027
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, gastrointestinal diseases, mortality, multiple organ failure